GA
ABBV icon

Gateway Advisory’s AbbVie ABBV Stock Holding History

Gateway Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,287
Closed -$2.15M – 74
2017
Q4 		$2.15M Sell
22,287
-1,045
-4% -$98.5K 0.6% 35
2017
Q3 		$2.07M Sell
23,332
-704
-3% -$53.6K 0.62% 34
2017
Q2 		$1.74M Buy
+24,036
New +$1.62M 0.54% 40

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gateway Advisory's ABBV Position: Q1 2018 in Review

Gateway Advisory sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 22,287 shares — an estimated $2.15M sold.

Gateway Advisory first reported a position in ABBV in Q2 2017 and held it in 3 quarters. The position peaked at $2.15M in Q4 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Gateway Advisory reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • Gateway Advisory sold 22,287 AbbVie shares in Q1 2018, an estimated $2.15M.
  • Gateway Advisory first reported a position in AbbVie in Q2 2017 and held it in 3 quarters.
  • Gateway Advisory's AbbVie position peaked at $2.15M in Q4 2017.
  • 2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Gateway Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.